SAFELY COLLECT AND STORE HEPATOCYTES
USE THE HIVE™ SOLUTION TO HARVEST SINGLE CELL FROM LIVER SAMPLES
Key Takeaways
- Robust mRNA expression with HIVE™ scRNAseq Solution
- HIVE™ scRNAseq Solution captures the diverse liver microenvironment
HIVE™ Single-cell RNAseq Hepatocyte Profiling without Fearing Total Sample Loss
Liver samples1,2 are notoriously difficult for single-cell platforms. About 80% of liver cells are hepatocytes,3 cells that are large enough to clog microfluidic devices while fragile enough to be destroyed in shear flow. Given the high risk of total failure, researchers often freeze such tissues and isolate nuclei for RNAseq, compromising the amount of mRNA recovered and leading to sparse data.
The HIVE™ technology offers new capabilities to perform scRNAseq from freshly digested liver samples. With gravity or a low-speed spin, single hepatocytes can gently settle into HIVE™ picowells (60 µm size). Extremely large cells, clumps, or debris that can clog other technologies are washed away from the HIVE™ device, and isolated hepatocytes are ready for whole-cell scRNAseq or can be stably frozen for months on end.

Study Parameters
Seamless HIVE™ Workflow
- Freshly dissociated cells from mouse livers
- 2 healthy samples, 1 tumor biopsy
- Enriched for hepatocytes (20–50 mm)
- Captured single cells with the HIVE™ scRNAseq Solution
- Stored at -20°C for 1.5 weeks before generating scRNAseq libraries
scRNAseq metrics*
Liver Type | Cells | Unique Genes | Unique Transcripts | Total Reads |
---|---|---|---|---|
Healthy | 812 | 1,769 | 4,676 | 44,017 |
Tumor | 915 | 2,773 | 6,862 | 39,186 |
*median values
scRNAseq by Sample Type

UMAP plot filtered for >50 genes, >100 transcripts, and cluster quality based on mitochondrial and ribosomal reads
Robust mRNA Expression with HIVE™ scRNAseq

HIVE™ Captures the Diverse Liver Microenvironment
Healthy liver
- 87% normal hepatocytes (Hep-PC/PP)
- 7% endothelial cells (LSEC)
- 4% macrophages (Kupffer)
- 1% pericytes (HSC), 1% immune cells
Liver tumor
- 60% tumor cells
- 7% normal hepatocytes (Hep-PC/PP)
- Expansion of immune cells (15%), endothelial cells (LSEC, 11%) and pericytes (HSC, 4%)

References
- Bissig-Choisat, B., Alves-Bezerra, M., Zorman, B. et al. A human liver chimeric mouse model for non-alcoholic fatty liver disease. JHEP Rep 3, 100281 (2021). https://doi.org/10.1016/j.jhepr.2021.100281
- Yuan, L., Liu, X., Zhang, L. et al. A chimeric humanized mouse model by engrafting the human induced pluripotent stem cell-derived hepatocyte-like cell for the chronic Hepatitis B virus infection. Front Microbiol 9, 908 (2018). https://doi.org/10.3389/fmicb.2018.00908
- Schulze, R., Schott, M., Casey, C. et al. The cell biology of the hepatocyte: A membrane trafficking machine. J Cell Biol 218, 2096 (2019). https://doi.org/10.1083/jcb.201903090
For research use only. Not for use in diagnostic procedures.